Daré Bioscience, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $26.3M | $21.3M | $10.5M |
| FY2024 | $28.1M | $22.1M | $15.7M |
| FY2025 | $29.6M | $32.5M | $24.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $26.3M | $21.3M | $10.5M |
| FY2024 | $28.1M | $22.1M | $15.7M |
| FY2025 | $29.6M | $32.5M | $24.7M |